<DOC>
	<DOCNO>NCT00289848</DOCNO>
	<brief_summary>This clinical study determine safety efficacy investigational drug patient type 2 diabetes mellitus .</brief_summary>
	<brief_title>MK0431 Monotherapy Study Patients With Type 2 Diabetes Mellitus ( 0431-040 )</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Sitagliptin Phosphate</mesh_term>
	<criteria>Patients Type 2 Diabetes Mellitus laboratory result within value establish study Hemoglobin A1c ( HbA1c ) &gt; =7.5 % &lt; =11 % Fasting Plasma Glucose ( FPG ) &gt; =130 mg/dL &lt; =280 mg/dL Exclusion Criteria : Patients Type 1 Diabetes Mellitus require insulin therapy within past 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>